Our attorneys possess a wide range of skills and experience across the life sciences industry. We have counseled companies at all stages of development—from start-ups to established industry leaders—in areas including biotechnology, bioenergy, medical devices, and nutraceutical. Our patent attorneys regularly prosecute patent applications, prepare patent validity analyses and opinions, and handle patent portfolio management. They also have substantial experience in conducting freedom-to-operate assessments and product clearances for bioscience products. We also have represented brand and generic companies in patent litigation involving many blockbuster drugs, including Prozac®, Lovenox®, Augmentin®, Concerta®, Strattera® and Cymbalta®. Our transactional attorneys have negotiated and closed hundreds of deals for bioscience companies, regularly handling venture capital financings, private offerings, mergers and acquisitions and corporate start-ups.